Craneware plc Dividend Currency Election (1097G)
March 25 2022 - 10:16AM
UK Regulatory
TIDMCRW
RNS Number : 1097G
Craneware plc
25 March 2022
Craneware plc
("Craneware" or the "Company" or the "Group")
Dividend Currency Election
25 March 2022 - Craneware plc (AIM: CRW.L), the market leader in
Value Cycle software solutions for the US healthcare market, today
gives further information regarding its interim dividend announced
on 14 March 2022.
For those shareholders who have previously registered to receive
their dividend in US dollars under the Company's Dividend Currency
Election, the dividend will be paid at an exchange rate of
$1.32.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Hilary Buchanan, Joe Pederzolli craneware@almapr.co.uk
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster, Andrew Clark
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint Broker ) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff
About Craneware
We at the Craneware Group of companies, including our latest
additions Sentry Data Systems and Agilum Healthcare Intelligence,
passionately believe we can impact healthcare profoundly by
delivering the insights healthcare organizations need to also
transform the business of healthcare. Our shared vision is to be
the operational and financial partner for U.S. healthcare
providers.
Our combined suite of applications and industry-leading team of
experts help our customers contextualize operational, financial,
and clinical data, providing insights that clearly demonstrate what
great looks like. These value cycle insights deliver revenue
integrity and 340B compliance, as well as margin and operational
intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now
our customers, including more than 2,000 U.S hospitals and health
systems and almost 10,000 clinics and affiliated retail pharmacies.
Our customers are operating with a financial impact of nearly half
a trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DIVEALDSAFLAEFA
(END) Dow Jones Newswires
March 25, 2022 10:16 ET (14:16 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2023 to Apr 2024